- Home
- AUPH vs ICFI Comparison
AUPH vs ICFI Comparison
Compare AUPH & ICFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AUPH | ICFI |
|---|---|---|
| Founded | 1993 | 1969 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.7B |
| IPO Year | 1999 | 2006 |
Fundamental Metrics
Financial Performance| Metric | AUPH | ICFI |
|---|---|---|
| Price | $15.20 | $84.93 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 4 |
| Target Price | $17.25 | ★ $98.00 |
| AVG Volume (30 Days) | ★ 1.1M | 147.0K |
| Earning Date | 11-04-2025 | 10-30-2025 |
| Dividend Yield | N/A | ★ 0.66% |
| EPS Growth | ★ N/A | N/A |
| EPS | 0.55 | ★ 5.30 |
| Revenue | $265,808,000.00 | ★ $1,925,502,000.00 |
| Revenue This Year | $21.76 | N/A |
| Revenue Next Year | $16.45 | $2.52 |
| P/E Ratio | $28.99 | ★ $16.10 |
| Revenue Growth | ★ 20.62 | N/A |
| 52 Week Low | $6.55 | $72.03 |
| 52 Week High | $16.54 | $135.34 |
Technical Indicators
Market Signals| Indicator | AUPH | ICFI |
|---|---|---|
| Relative Strength Index (RSI) | 43.08 | 50.58 |
| Support Level | $15.64 | $84.24 |
| Resistance Level | $15.98 | $89.11 |
| Average True Range (ATR) | 0.39 | 2.30 |
| MACD | -0.13 | -0.14 |
| Stochastic Oscillator | 13.73 | 16.39 |
Price Performance
Historical ComparisonAbout AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
About ICFI ICF International Inc.
ICF International Inc provides professional services and technology-based solutions to government and commercial clients, including management, marketing, technology, and policy consulting and implementation services. Its services support clients that operate in four key markets that include Energy, Environment, Infrastructure and Disaster Recovery; Health and Social Programs and Security and Other Civilian & Commercial. The Company's majority clients are United States federal government departments and agencies. It operates in a single segment, which is providing professional services.